Bionoid Pharma is selling at 0.23 as of the 3rd of December 2024; that is 109.09 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.23. Bionoid Pharma has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Bionoid Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of December 2022 and ending today, the 3rd of December 2024. Click here to learn more.
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people. The company has 42.28 M outstanding shares. More on Bionoid Pharma
Bionoid Pharma [BINP] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bionoid Pharma's market, we take the total number of its shares issued and multiply it by Bionoid Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bionoid Pharma conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 42.28 M outstanding shares.
Bionoid Pharma currently holds about 127 in cash with (357.62 K) of positive cash flow from operations.
Check Bionoid Pharma Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Bionoid Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Headlines Timeline Now
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.